Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to -$1.8 million.

  • Rockwell Medical's Consolidated Net Income fell 20901.44% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.7 million, marking a year-over-year decrease of 31210.37%. This contributed to the annual value of -$554000.0 for FY2024, which is 9367.58% up from last year.
  • According to the latest figures from Q3 2025, Rockwell Medical's Consolidated Net Income is -$1.8 million, which was down 20901.44% from -$1.6 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Consolidated Net Income registered a high of $1.7 million during Q3 2024, and its lowest value of -$8.9 million during Q4 2021.
  • For the 5-year period, Rockwell Medical's Consolidated Net Income averaged around -$3.5 million, with its median value being -$2.1 million (2023).
  • In the last 5 years, Rockwell Medical's Consolidated Net Income soared by 17954.11% in 2024 and then plummeted by 63287.67% in 2025.
  • Rockwell Medical's Consolidated Net Income (Quarter) stood at -$8.9 million in 2021, then soared by 73.59% to -$2.4 million in 2022, then skyrocketed by 31.71% to -$1.6 million in 2023, then surged by 51.7% to -$779000.0 in 2024, then plummeted by 132.86% to -$1.8 million in 2025.
  • Its last three reported values are -$1.8 million in Q3 2025, -$1.6 million for Q2 2025, and -$1.6 million during Q1 2025.